Anaphylaxis in the New Millennium

Anaphylaxis continues to challenge patients and healthcare providers because of the variety of ways it can manifest. This course - a recording of a plenary session presented at the AAAAI 2012 Annual Meeting in Orlando, FL - reviews the immunologic mechanisms of anaphylaxis, including non-IgE mediated anaphylaxis; reasons the heart is an important target in the diagnosis and management of anaphylaxis; and summarizes the assessment and management guidelines for anaphylaxis from the World Allergy Organization.

The Anaphylaxis Identification and Management (AIM) initiative is funded through an educational grant from sanofi-aventis, U.S.

Target Audience

Allergist/Immunologists

Allied health providers working in allergy/immunology clinics

Allergy/immunology trainees

Healthcare providers treating patients at risk of an anaphylactic reaction

Learning Objectives

Upon completion of this session, participants should be able to:

1. Describe immunologic mechanisms in anaphylaxis, including non-IgE-mediated

2. Explain why the heart is an important target

3. State the unique principles of anaphylaxis assessment and management promulgated in the World Allergy Organization Anaphylaxis Guidelines.

Summary

Available credit: 
  • 1.50 Attendance
    Attendance credit.
  • 1.80 CE
    CE credit.
  • 1.50 CME
    CME credit.
Course opens: 
09/10/2012
Course expires: 
06/29/2015
Cost:
$0.00

Vivian P. Hernandez-Trujillo, MD FAAAAI

Miami Children's Hospital (Director, Division of Allergy/Immunology)

Stephen J. Galli, MD

Stanford University School Medicine (Chair, Dept of Pathology)

Dean D. Metcalfe, MD FAAAAI

NIAID/NIH (Chief, Lab Allergic Diseases)

F. Estelle R. Simons, MD FAAAAI

University of Manitoba (Professor, Section of Allergy and Clinical Immunology)

Available Credit

  • 1.50 Attendance
    Attendance credit.
  • 1.80 CE
    CE credit.
  • 1.50 CME
    CME credit.

Price

Cost:
$0.00
Please login or register to take this course.